The stock market trading debut comes as incoming President Trump has said he plans to boost America’s energy production.

Venture Global's IPO represents a test for investor appetite for fossil fuel projects in the Trump administration.

Dr. Dajun Yang, Ascentage Pharma CEO, joins 'Closing Bell Overtime' to talk today's IPO. Marilyn Manson won’t face sexual ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

Private credit lenders are flocking to finance large, fast-growing technology companies gearing up to go public, taking ...

Voyager Technologies has reportedly filed its confidential paperwork to go public, hoping for a $2 billion to $3 billion ...

Private equity-backed Northpointe Bancshares filed for an initial public offering in the United States on Thursday, setting ...

In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...

Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.

The energy company raised $1.75 billion by pricing 70 million shares at $25, the middle of its reduced $23 to $27 price range ...

Shares of liquefied natural gas exporter Venture Global finished Friday's first day of trading below their initial public ...